← Back to patent-cliff list
CAS 456-42-8
1-(chloromethyl)-3-fluorobenzene
Codes: SAFI-001
Application context (from source-drug indications)
Parkinson's diseaseSafinamide MesylatePainSafinamide MesylateDrug-induced dyskinesiaSafinamide MesylateHepatic function declineSafinamide MesylateMultiple system atrophySafinamide MesylateRenal impairmentSafinamide Mesylate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Safinamide Mesylate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(chloromethyl)-3-fluorobenzene→4-hydroxybenzaldehyde→4-((3-fluorobenzyl)oxy)benzaldehyde→(S)-2-aminopropanamide hydrochloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.